David Green

David Green is a declared insider at 2 companies (chief executive); the most frequent names are Harvard Apparatus Regenerative Technology, Inc. and Harvard Bioscience Inc. Between 1 January 2016 and 12 May 2022, the trades on record add up to 4 filings.

No open-market sale appears; the market trades are 2 purchases worth €584k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. In 2022 alone, the filings show 1 purchase and no sales.

The newest entry dates from 23 May 2022: an open-market purchase of €361k, in Harvard Apparatus Regenerative Technology, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.